Skip to main content

Advertisement

SpringerLink
Log in

Autoimmunity in 2014

  • Published:
Clinical Reviews in Allergy & Immunology Aims and scope Submit manuscript

Abstract

Our PubMed search for peer-reviewed articles published in the 2014 solar year retrieved a significantly higher number of hits compared to 2013 with a net 28 % increase. Importantly, full articles related to autoimmunity constitute approximately 5 % of immunology articles. We confirm that our understanding of autoimmunity is becoming a translational paradigm with pathogenetic elements rapidly followed by new treatment options. Furthermore, numerous clinical and pathogenetic elements and features are shared among autoimmune diseases, and this is well illustrated in the recent literature. More specifically, the past year witnessed critical revisions of our understanding and management of antiphospholipid syndrome with new exciting data on the pathogenicity of the serum anti-beta2 glycoprotein autoantibody, a better understanding of the current and new treatments for rheumatoid arthritis, and new position papers on important clinical questions such as vaccinations in patients with autoimmune disease, comorbidities, or new classification criteria. Furthermore, data confirming the important connections between innate immunity and autoimmunity via toll-like receptors or the critical role of T regulatory cells in tolerance breakdown and autoimmunity perpetuation were also reported. Lastly, genetic and epigenetic data were provided to confirm that the mosaic of autoimmunity warrants a susceptible individual background which may be geographically determined and contribute to the geoepidemiology of diseases. The 2014 literature in the autoimmunity world should be cumulatively regarded as part of an annus mirabilis in which, on a different level, the 2014 Annual Meeting of the American College of Rheumatology in Boston was attended by over 16,000 participants with over selected 3000 abstracts.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Selmi C (2014) Autoimmunity in 2013. Clin Rev Allergy Immunol 47:100–109

    Article  CAS  PubMed  Google Scholar 

  2. Dias C, Selmi C (2014) The challenge of treating orphan disease. Clin Rev Allergy Immunol 47:259–263

    Article  CAS  PubMed  Google Scholar 

  3. Caso F, Costa L, Rigante D et al (2014) Caveats and truths in genetic, clinical, autoimmune and autoinflammatory issues in Blau syndrome and early onset sarcoidosis. Autoimmun Rev 13:1220–1229

    Article  PubMed  Google Scholar 

  4. Comarmond C, Wechsler B, Bodaghi B, Cacoub P, Saadoun D (2014) Biotherapies in Behcet's disease. Autoimmun Rev 13:762–769

    Article  PubMed  Google Scholar 

  5. Ozyazgan Y, Ucar D, Hatemi G, Yazici Y (2014) Ocular involvement of Behcet's syndrome: a comprehensive review. Clin Rev Allergy Immunol. doi:10.1007/s12016-014-8425-z

  6. Schwartzman S, Schwartzman M (2014) The use of biologic therapies in Uveitis. Clin Rev Allergy Immunol. doi:10.1007/s12016-014-8455-6

  7. Selmi C (2014) Diagnosis and classification of autoimmune uveitis. Autoimmun Rev 13:591–594

    Article  CAS  PubMed  Google Scholar 

  8. Yazici H, Yazici Y (2014) Criteria for Behcet's disease with reflections on all disease criteria. J Autoimmun 48–49:104–107

    Article  PubMed  CAS  Google Scholar 

  9. Cantarini L, Vitale A, Brizi MG et al (2014) Diagnosis and classification of relapsing polychondritis. J Autoimmun 48–49:53–59

    Article  PubMed  CAS  Google Scholar 

  10. Arnaud L, Mathian A, Haroche J, Gorochov G, Amoura Z (2014) Pathogenesis of relapsing polychondritis: a 2013 update. Autoimmun Rev 13:90–95

    Article  CAS  PubMed  Google Scholar 

  11. Thai LH, Charles P, Resche-Rigon M, Desseaux K, Guillevin L (2014) Are anti-proteinase-3 ANCA a useful marker of granulomatosis with polyangiitis (Wegener's) relapses? Results of a retrospective study on 126 patients. Autoimmun Rev 13:313–318

    Article  CAS  PubMed  Google Scholar 

  12. Mouthon L, Dunogue B, Guillevin L (2014) Diagnosis and classification of eosinophilic granulomatosis with polyangiitis (formerly named Churg-Strauss syndrome). J Autoimmun 48–49:99–103

    Article  PubMed  CAS  Google Scholar 

  13. Monti G, Saccardo F, Castelnovo L et al (2014) Prevalence of mixed cryoglobulinaemia syndrome and circulating cryoglobulins in a population-based survey: the Origgio study. Autoimmun Rev 13:609–614

    Article  CAS  PubMed  Google Scholar 

  14. Chimenti MS, Ballanti E, Triggianese P, Perricone R (2014) Vasculitides and the complement system: a comprehensive review. Clin Rev Allergy Immunol. doi:10.1007/s12016-014-8453-8

  15. Comarmond C, Cacoub P (2014) Granulomatosis with polyangiitis (Wegener): clinical aspects and treatment. Autoimmun Rev 13:1121–1125

    Article  PubMed  Google Scholar 

  16. Hellmark T, Segelmark M (2014) Diagnosis and classification of Goodpasture's disease (anti-GBM). J Autoimmun 48–49:108–112

    Article  PubMed  CAS  Google Scholar 

  17. Avidan N, Le Panse R, Berrih-Aknin S, Miller A (2014) Genetic basis of myasthenia gravis—a comprehensive review. J Autoimmun 52:146–153

    Article  CAS  PubMed  Google Scholar 

  18. Berrih-Aknin S, Le Panse R (2014) Myasthenia gravis: a comprehensive review of immune dysregulation and etiological mechanisms. J Autoimmun 52:90–100

    Article  CAS  PubMed  Google Scholar 

  19. Berrih-Aknin S, Frenkian-Cuvelier M, Eymard B (2014) Diagnostic and clinical classification of autoimmune myasthenia gravis. J Autoimmun 48–49:143–148

    Article  PubMed  CAS  Google Scholar 

  20. Berrih-Aknin S (2014) Myasthenia Gravis: paradox versus paradigm in autoimmunity. J Autoimmun 52:1–28

    Article  CAS  PubMed  Google Scholar 

  21. Hernandez-Trujillo V (2014) New genetic discoveries and primary immune deficiencies. Clin Rev Allergy Immunol 46:145–153

    Article  CAS  PubMed  Google Scholar 

  22. Ballow M (2014) Historical perspectives in the diagnosis and treatment of primary immune deficiencies. Clin Rev Allergy Immunol 46:101–103

    Article  CAS  PubMed  Google Scholar 

  23. Cutolo M (2014) Autoimmune polyendocrine syndromes. Autoimmun Rev 13:85–89

    Article  CAS  PubMed  Google Scholar 

  24. Ben-Dov I, Segel MJ (2014) Autoimmune pulmonary alveolar proteinosis: clinical course and diagnostic criteria. Autoimmun Rev 13:513–517

    Article  CAS  PubMed  Google Scholar 

  25. Betterle C, Garelli S, Presotto F (2014) Diagnosis and classification of autoimmune parathyroid disease. Autoimmun Rev 13:417–422

    Article  CAS  PubMed  Google Scholar 

  26. Bizzaro N, Antico A (2014) Diagnosis and classification of pernicious anemia. Autoimmun Rev 13:565–568

    Article  PubMed  Google Scholar 

  27. Bowlus CL, Gershwin ME (2014) The diagnosis of primary biliary cirrhosis. Autoimmun Rev 13:441–444

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  28. Braithwaite T, Holder GE, Lee RW, Plant GT, Tufail A (2014) Diagnostic features of the autoimmune retinopathies. Autoimmun Rev 13:534–538

    Article  CAS  PubMed  Google Scholar 

  29. Brandao Neto RA, de Carvalho JF (2014) Diagnosis and classification of Addison's disease (autoimmune adrenalitis). Autoimmun Rev 13:408–411

    Article  CAS  PubMed  Google Scholar 

  30. Burke RJ, Chang C (2014) Diagnostic criteria of acute rheumatic fever. Autoimmun Rev 13:503–507

    Article  PubMed  Google Scholar 

  31. Chang HH, Chiang BL (2014) The diagnosis and classification of autoimmune coagulopathy: an updated review. Autoimmun Rev 13:587–590

    Article  CAS  PubMed  Google Scholar 

  32. Greco A, De Virgilio A, Gallo A et al (2014) Susac's syndrome—pathogenesis, clinical variants and treatment approaches. Autoimmun Rev 13:814–821

    Article  CAS  PubMed  Google Scholar 

  33. Zhao H, Zhang Y, Xiao G, Wu N, Xu J, Fang Z (2014) Interleukin-18 gene promoter—607 A/C polymorphism and the risk of immune thrombocytopenia. Autoimmunity 47:478–481

    Article  CAS  PubMed  Google Scholar 

  34. Goebel A (2014) Immune activation and autoimmunity in chronic pain conditions and response to immunoglobulin G. Clin Exp Immunol 178(Suppl 1):39–41

    Article  PubMed  PubMed Central  Google Scholar 

  35. Jarius S, Wildemann B, Paul F (2014) Neuromyelitis optica: clinical features, immunopathogenesis and treatment. Clin Exp Immunol 176:149–164

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  36. Cohen IR (2014) Activation of benign autoimmunity as both tumor and autoimmune disease immunotherapy: a comprehensive review. J Autoimmun 54:112–117

    Article  CAS  PubMed  Google Scholar 

  37. Saito Y, Saito H, Liang G, Friedman JM (2014) Epigenetic alterations and microRNA misexpression in cancer and autoimmune diseases: a critical review. Clin Rev Allergy Immunol 47:128–135

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Colaci M, Giuggioli D, Vacchi C et al (2014) Breast cancer in systemic sclerosis: results of a cross-linkage of an Italian Rheumatologic Center and a population-based Cancer Registry and review of the literature. Autoimmun Rev 13:132–137

    Article  PubMed  Google Scholar 

  39. Bernal-Bello D, Garcia de Tena J, Simeon-Aznar C, Fonollosa-Pla V (2014) Systemic sclerosis, breast cancer and calcium channel blockers: a new player on the scene? Autoimmun Rev 13:880–881

    Article  CAS  PubMed  Google Scholar 

  40. Klarquist J, Hennies CM, Lehn MA, Reboulet RA, Feau S, Janssen EM (2014) STING-mediated DNA sensing promotes antitumor and autoimmune responses to dying cells. J Immunol 193:6124–6134

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  41. Selmi C (2014) Hot topics in autoimmune diseases: perspectives from the 2013 Asian Congress of Autoimmunity. Autoimmun Rev 13:781–787

    Article  PubMed  Google Scholar 

  42. Kuhn A, Landmann A (2014) The classification and diagnosis of cutaneous lupus erythematosus. J Autoimmun 48–49:14–19

    Article  PubMed  CAS  Google Scholar 

  43. Yu C, Gershwin ME, Chang C (2014) Diagnostic criteria for systemic lupus erythematosus: a critical review. J Autoimmun 48–49:10–13

    Article  PubMed  CAS  Google Scholar 

  44. Arnaud L, Fagot JP, Mathian A, Paita M, Fagot-Campagna A, Amoura Z (2014) Prevalence and incidence of systemic lupus erythematosus in France: a 2010 nation-wide population-based study. Autoimmun Rev 13:1082–1089

    Article  PubMed  Google Scholar 

  45. Cervera R, Doria A, Amoura Z et al (2014) Patterns of systemic lupus erythematosus expression in Europe. Autoimmun Rev 13:621–629

    Article  CAS  PubMed  Google Scholar 

  46. Cheng FJ, Zhou XJ, Zhao YF, Zhao MH, Zhang H (2014) Chemokine receptor 5 (CCR5) delta 32 polymorphism in lupus nephritis: a large case–control study and meta-analysis. Autoimmunity 47:383–388

    Article  CAS  PubMed  Google Scholar 

  47. Ni J, Zhang M, Zhu Y et al (2014) Association study of interleukin-19 rs2243188 polymorphism with systemic lupus erythematosus in a Chinese population. Autoimmunity 47:378–382

    Article  CAS  PubMed  Google Scholar 

  48. Vigato-Ferreira IC, Toller-Kawahisa JE, Pancoto JA et al (2014) FcgammaRIIa and FcgammaRIIIb polymorphisms and associations with clinical manifestations in systemic lupus erythematosus patients. Autoimmunity 47:451–458

    Article  CAS  PubMed  Google Scholar 

  49. Ruiz-Irastorza G, Danza A, Perales I et al (2014) Prednisone in lupus nephritis: how much is enough? Autoimmun Rev 13:206–214

    Article  CAS  PubMed  Google Scholar 

  50. Sthoeger Z, Sharabi A, Mozes E (2014) Novel approaches to the development of targeted therapeutic agents for systemic lupus erythematosus. J Autoimmun 54:60–71

    Article  CAS  PubMed  Google Scholar 

  51. Gustafsson JT, Svenungsson E (2014) Definitions of and contributions to cardiovascular disease in systemic lupus erythematosus. Autoimmunity 47:67–76

    Article  CAS  PubMed  Google Scholar 

  52. Zard E, Arnaud L, Mathian A et al (2014) Increased risk of high grade cervical squamous intraepithelial lesions in systemic lupus erythematosus: A meta-analysis of the literature. Autoimmun Rev 13:730–735

    Article  PubMed  Google Scholar 

  53. Gomez-Puerta JA, Cervera R (2014) Diagnosis and classification of the antiphospholipid syndrome. J Autoimmun 48–49:20–25

    Article  PubMed  CAS  Google Scholar 

  54. Arnaud L, Mathian A, Ruffatti A et al (2014) Efficacy of aspirin for the primary prevention of thrombosis in patients with antiphospholipid antibodies: an international and collaborative meta-analysis. Autoimmun Rev 13:281–291

    Article  CAS  PubMed  Google Scholar 

  55. Cervera R, Rodriguez-Pinto I, Colafrancesco S et al (2014) 14th International Congress on Antiphospholipid Antibodies Task Force Report on Catastrophic Antiphospholipid Syndrome. Autoimmun Rev 13:699–707

    Article  PubMed  Google Scholar 

  56. de Jesus GR, Agmon-Levin N, Andrade CA et al (2014) 14th International Congress on Antiphospholipid Antibodies Task Force report on obstetric antiphospholipid syndrome. Autoimmun Rev 13:795–813

    Article  PubMed  Google Scholar 

  57. Erkan D, Aguiar CL, Andrade D et al (2014) 14th International Congress on Antiphospholipid Antibodies: task force report on antiphospholipid syndrome treatment trends. Autoimmun Rev 13:685–696

    Article  CAS  PubMed  Google Scholar 

  58. Berman H, Rodriguez-Pinto I, Cervera R et al (2014) Pediatric catastrophic antiphospholipid syndrome: descriptive analysis of 45 patients from the "CAPS Registry". Autoimmun Rev 13:157–162

    Article  PubMed  Google Scholar 

  59. Jeltsch-David H, Muller S (2014) Neuropsychiatric systemic lupus erythematosus and cognitive dysfunction: the MRL-lpr mouse strain as a model. Autoimmun Rev 13:963–973

    Article  PubMed  Google Scholar 

  60. D'Ippolito S, Meroni PL, Koike T, Veglia M, Scambia G, Di Simone N (2014) Obstetric antiphospholipid syndrome: a recent classification for an old defined disorder. Autoimmun Rev 13:901–908

    Article  PubMed  Google Scholar 

  61. Katzav A, Menachem A, Maggio N, Pollak L, Pick CG, Chapman J (2014) IgG accumulates in inhibitory hippocampal neurons of experimental antiphospholipid syndrome. J Autoimmun 55:86–93

    Article  CAS  PubMed  Google Scholar 

  62. Raschi E, Chighizola CB, Grossi C et al (2014) beta2-glycoprotein I, lipopolysaccharide and endothelial TLR4: three players in the two hit theory for anti-phospholipid-mediated thrombosis. J Autoimmun 55:42–50

    Article  CAS  PubMed  Google Scholar 

  63. Zandman-Goddard G, Pierangeli SS, Gertel S, Blank M (2014) Tolerogenic dendritic cells specific for beta2-glycoprotein-I Domain-I, attenuate experimental antiphospholipid syndrome. J Autoimmun 54:72–80

    Article  CAS  PubMed  Google Scholar 

  64. Korabecna M, Ulcova-Gallova Z, Horinek A, Pazourkova E, Calda P (2014) Quantification of circulating fetal DNA as a tool for potential monitoring of pregnant patients with antiphospholipid antibodies. Autoimmunity 47:473–477

    Article  CAS  PubMed  Google Scholar 

  65. Reynaud Q, Lega JC, Mismetti P et al (2014) Risk of venous and arterial thrombosis according to type of antiphospholipid antibodies in adults without systemic lupus erythematosus: a systematic review and meta-analysis. Autoimmun Rev 13:595–608

    Article  CAS  PubMed  Google Scholar 

  66. Tozzoli R, Villalta D (2014) Autoantibody profiling of patients with antiphospholipid syndrome using an automated multiplexed immunoassay system. Autoimmun Rev 13:59–63

    Article  CAS  PubMed  Google Scholar 

  67. Staub HL, Dal Ben ER, Bauer ME (2014) The antiphospholipid syndrome and Tregs. Autoimmun Rev 13:697–698

    Article  PubMed  Google Scholar 

  68. Xiao X, Chang C (2014) Diagnosis and classification of drug-induced autoimmunity (DIA). J Autoimmun 48–49:66–72

    Article  PubMed  CAS  Google Scholar 

  69. Tani C, Carli L, Vagnani S et al (2014) The diagnosis and classification of mixed connective tissue disease. J Autoimmun 48–49:46–49

    Article  PubMed  CAS  Google Scholar 

  70. Calixto OJ, Franco JS, Anaya JM (2014) Lupus mimickers. Autoimmun Rev 13:865–872

    Article  CAS  PubMed  Google Scholar 

  71. Murdaca G, Orsi A, Spano F et al (2014) Influenza and pneumococcal vaccinations of patients with systemic lupus erythematosus: current views upon safety and immunogenicity. Autoimmun Rev 13:75–84

    Article  CAS  PubMed  Google Scholar 

  72. Ben-Ami Shor D, Blank M, Reuter S et al (2014) Anti-ribosomal-P antibodies accelerate lupus glomerulonephritis and induce lupus nephritis in naive mice. J Autoimmun 54:118–126

    Article  CAS  PubMed  Google Scholar 

  73. Gesheva V, Kerekov N, Nikolova K et al (2014) Suppression of dsDNA-specific B lymphocytes reduces disease symptoms in SCID model of mouse lupus. Autoimmunity 47:162–172

    Article  CAS  PubMed  Google Scholar 

  74. Fali T, Le Dantec C, Thabet Y et al (2014) DNA methylation modulates HRES1/p28 expression in B cells from patients with Lupus. Autoimmunity 47:265–271

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  75. Hedrich CM, Crispin JC, Tsokos GC (2014) Epigenetic regulation of cytokine expression in systemic lupus erythematosus with special focus on T cells. Autoimmunity 47:234–241

    Article  CAS  PubMed  Google Scholar 

  76. Liu A, La Cava A (2014) Epigenetic dysregulation in systemic lupus erythematosus. Autoimmunity 47:215–219

    Article  PubMed  Google Scholar 

  77. Oaks Z, Perl A (2014) Metabolic control of the epigenome in systemic Lupus erythematosus. Autoimmunity 47:256–264

    Article  PubMed Central  PubMed  Google Scholar 

  78. Liang Y, Xu WD, Yang XK et al (2014) Association of signaling transducers and activators of transcription 1 and systemic lupus erythematosus. Autoimmunity 47:141–145

    Article  CAS  PubMed  Google Scholar 

  79. Kuhn A, Wenzel J, Weyd H (2014) Photosensitivity, apoptosis, and cytokines in the pathogenesis of lupus erythematosus: a critical review. Clin Rev Allergy Immunol 47:148–162

    Article  CAS  PubMed  Google Scholar 

  80. Tang X, Zhang B, Jarrell JA et al (2014) Ly108 expression distinguishes subsets of invariant NKT cells that help autoantibody production and secrete IL-21 from those that secrete IL-17 in lupus prone NZB/W mice. J Autoimmun 50:87–98

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  81. Liu Y, Liu A, Iikuni N, Xu H, Shi FD, La Cava A (2014) Regulatory CD4+ T cells promote B cell anergy in murine lupus. J Immunol 192:4069–4073

    Article  CAS  PubMed  Google Scholar 

  82. Miyake K, Adachi K, Watanabe M et al (2014) Parasites alter the pathological phenotype of lupus nephritis. Autoimmunity 47:538–547

    Article  PubMed Central  PubMed  Google Scholar 

  83. Maizels RM, McSorley HJ, Smyth DJ (2014) Helminths in the hygiene hypothesis: sooner or later? Clin Exp Immunol 177:38–46

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  84. Rigante D, Mazzoni MB, Esposito S (2014) The cryptic interplay between systemic lupus erythematosus and infections. Autoimmun Rev 13:96–102

    Article  CAS  PubMed  Google Scholar 

  85. Zan H (2014) Epigenetics in lupus. Autoimmunity 47:213–214

    Article  CAS  PubMed  Google Scholar 

  86. Zan H, Tat C, Casali P (2014) MicroRNAs in lupus. Autoimmunity 47:272–285

    Article  PubMed Central  PubMed  Google Scholar 

  87. Rogatsky I, Chandrasekaran U, Manni M, Yi W, Pernis AB (2014) Epigenetics and the IRFs: a complex interplay in the control of immunity and autoimmunity. Autoimmunity 47:242–255

    Article  CAS  PubMed  Google Scholar 

  88. Summers SA, Odobasic D, Khouri MB et al (2014) Endogenous interleukin (IL)-17A promotes pristane-induced systemic autoimmunity and lupus nephritis induced by pristane. Clin Exp Immunol 176:341–350

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  89. Wei R, Dong L, Xiao Q, Sun D, Li X, Nian H (2014) Engagement of Toll-like receptor 2 enhances interleukin (IL)-17(+) autoreactive T cell responses via p38 mitogen-activated protein kinase signalling in dendritic cells. Clin Exp Immunol 178:353–363

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  90. Zhong J, Yu Q, Yang P et al (2014) MBD2 regulates TH17 differentiation and experimental autoimmune encephalomyelitis by controlling the homeostasis of T-bet/Hlx axis. J Autoimmun 53:95–104

    Article  CAS  PubMed  Google Scholar 

  91. Seror R, Theander E, Bootsma H et al (2014) Outcome measures for primary Sjogren's syndrome: a comprehensive review. J Autoimmun 51:51–56

    Article  PubMed  Google Scholar 

  92. Moutsopoulos HM (2014) Sjogren's syndrome: a forty-year scientific journey. J Autoimmun 51:1–9

    Article  CAS  PubMed  Google Scholar 

  93. Goules AV, Tzioufas AG, Moutsopoulos HM (2014) Classification criteria of Sjogren's syndrome. J Autoimmun 48–49:42–45

    Article  PubMed  Google Scholar 

  94. De Carolis S, Salvi S, Botta A et al (2014) The impact of primary Sjogren's syndrome on pregnancy outcome: our series and review of the literature. Autoimmun Rev 13:103–107

    Article  PubMed  Google Scholar 

  95. Ziakas PD, Poulou LS, Thanos L (2014) Towards integrating positron emission tomography for work-up of patients with Sjogren's syndrome and associated lymphomas. Autoimmun Rev 13:327–329

    Article  PubMed  Google Scholar 

  96. Sumida T, Tsuboi H, Iizuka M, Hirota T, Asashima H, Matsumoto I (2014) The role of M3 muscarinic acetylcholine receptor reactive T cells in Sjogren's syndrome: a critical review. J Autoimmun 51:44–50

    Article  CAS  PubMed  Google Scholar 

  97. Moriyama M, Tanaka A, Maehara T, Furukawa S, Nakashima H, Nakamura S (2014) T helper subsets in Sjogren's syndrome and IgG4-related dacryoadenitis and sialoadenitis: a critical review. J Autoimmun 51:81–88

    Article  CAS  PubMed  Google Scholar 

  98. Alunno A, Carubbi F, Bistoni O et al (2014) CD4(−)CD8(−) T-cells in primary Sjogren's syndrome: association with the extent of glandular involvement. J Autoimmun 51:38–43

    Article  CAS  PubMed  Google Scholar 

  99. Aqrawi LA, Kvarnstrom M, Brokstad KA, Jonsson R, Skarstein K, Wahren-Herlenius M (2014) Ductal epithelial expression of Ro52 correlates with inflammation in salivary glands of patients with primary Sjogren's syndrome. Clin Exp Immunol 177:244–252

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  100. Alunno A, Carubbi F, Bartoloni E et al (2014) Unmasking the pathogenic role of IL-17 axis in primary Sjogren's syndrome: a new era for therapeutic targeting? Autoimmun Rev 13:1167–1173

    Article  CAS  PubMed  Google Scholar 

  101. Quartuccio L, Isola M, Baldini C et al (2014) Biomarkers of lymphoma in Sjogren's syndrome and evaluation of the lymphoma risk in prelymphomatous conditions: results of a multicenter study. J Autoimmun 51:75–80

    Article  PubMed  Google Scholar 

  102. Kourilovitch M, Galarza-Maldonado C, Ortiz-Prado E (2014) Diagnosis and classification of rheumatoid arthritis. J Autoimmun 48–49:26–30

    Article  PubMed  CAS  Google Scholar 

  103. Mahroum N, Mahagna H, Amital H (2014) Diagnosis and classification of adult Still's disease. J Autoimmun 48–49:34–37

    Article  PubMed  Google Scholar 

  104. Maria AT, Le Quellec A, Jorgensen C, Touitou I, Riviere S, Guilpain P (2014) Adult onset Still's disease (AOSD) in the era of biologic therapies: dichotomous view for cytokine and clinical expressions. Autoimmun Rev 13:1149–1159

    Article  CAS  PubMed  Google Scholar 

  105. Nesher G (2014) Polymyalgia rheumatica—diagnosis and classification. J Autoimmun 48–49:76–78

    Article  PubMed  CAS  Google Scholar 

  106. Rigante D, Bosco A, Esposito S (2014) The etiology of juvenile idiopathic arthritis. Clin Rev Allergy Immunol. doi:10.1007/s12016-014-8460-9

  107. Selmi C, Gershwin ME (2014) Diagnosis and classification of reactive arthritis. Autoimmun Rev 13:546–549

    Article  CAS  PubMed  Google Scholar 

  108. Raychaudhuri SP, Deodhar A (2014) The classification and diagnostic criteria of ankylosing spondylitis. J Autoimmun 48–49:128–133

    Article  PubMed  Google Scholar 

  109. Atzeni F, Defendenti C, Ditto MC et al (2014) Rheumatic manifestations in inflammatory bowel disease. Autoimmun Rev 13:20–23

    Article  PubMed  Google Scholar 

  110. Lin YZ, Li RN, Lin CH et al (2014) Association of OSMR gene polymorphisms with rheumatoid arthritis and systemic lupus erythematosus patients. Autoimmunity 47:23–26

    Article  CAS  PubMed  Google Scholar 

  111. Sakkas LI, Bogdanos DP, Katsiari C, Platsoucas CD (2014) Anti-citrullinated peptides as autoantigens in rheumatoid arthritis-relevance to treatment. Autoimmun Rev 13:1114–1120

    Article  CAS  PubMed  Google Scholar 

  112. Muller S, Radic M (2014) Citrullinated autoantigens: from diagnostic markers to pathogenetic mechanisms. Clin Rev Allergy Immunol. doi:10.1007/s12016-014-8459-2

  113. Joaquim AF, Appenzeller S (2014) Cervical spine involvement in rheumatoid arthritis—a systematic review. Autoimmun Rev 13:1195–1202

    Article  PubMed  Google Scholar 

  114. Lazzerini PE, Capecchi PL, Acampa M, Galeazzi M, Laghi-Pasini F (2014) Arrhythmic risk in rheumatoid arthritis: the driving role of systemic inflammation. Autoimmun Rev 13:936–944

    Article  PubMed  Google Scholar 

  115. Caetano-Lopes J, Rodrigues A, Lopes A et al (2014) Rheumatoid arthritis bone fragility is associated with upregulation of IL17 and DKK1 gene expression. Clin Rev Allergy Immunol 47:38–45

    Article  CAS  PubMed  Google Scholar 

  116. Cambridge G, Perry HC, Nogueira L et al (2014) The effect of B-cell depletion therapy on serological evidence of B-cell and plasmablast activation in patients with rheumatoid arthritis over multiple cycles of rituximab treatment. J Autoimmun 50:67–76

    Article  CAS  PubMed  Google Scholar 

  117. Liu Y, Yin H, Zhao M, Lu Q (2014) TLR2 and TLR4 in autoimmune diseases: a comprehensive review. Clin Rev Allergy Immunol 47:136–147

    Article  CAS  PubMed  Google Scholar 

  118. Savic S, Ouboussad L, Dickie LJ et al (2014) TLR dependent XBP-1 activation induces an autocrine loop in rheumatoid arthritis synoviocytes. J Autoimmun 50:59–66

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  119. Zavala-Cerna MG, Martinez-Garcia EA, Torres-Bugarin O, Rubio-Jurado B, Riebeling C, Nava A (2014) The clinical significance of posttranslational modification of autoantigens. Clin Rev Allergy Immunol 47:73–90

    Article  CAS  PubMed  Google Scholar 

  120. Chang C (2014) Unmet needs in the treatment of autoimmunity: from aspirin to stem cells. Autoimmun Rev 13:331–346

    Article  CAS  PubMed  Google Scholar 

  121. Chighizola CB, Favalli EG, Meroni PL (2014) Novel mechanisms of action of the biologicals in rheumatic diseases. Clin Rev Allergy Immunol 47:6–16

    Article  CAS  PubMed  Google Scholar 

  122. Alghasham A, Rasheed Z (2014) Therapeutic targets for rheumatoid arthritis: Progress and promises. Autoimmunity 47:77–94

    Article  CAS  PubMed  Google Scholar 

  123. Caporali R, Bugatti S, Cavagna L, Antivalle M, Sarzi-Puttini P (2014) Modulating the co-stimulatory signal for T cell activation in rheumatoid arthritis: could it be the first step of the treatment? Autoimmun Rev 13:49–53

    Article  CAS  PubMed  Google Scholar 

  124. Kaltsonoudis E, Voulgari PV, Konitsiotis S, Drosos AA (2014) Demyelination and other neurological adverse events after anti-TNF therapy. Autoimmun Rev 13:54–58

    Article  CAS  PubMed  Google Scholar 

  125. Piga M, Chessa E, Ibba V et al (2014) Biologics-induced autoimmune renal disorders in chronic inflammatory rheumatic diseases: systematic literature review and analysis of a monocentric cohort. Autoimmun Rev 13:873–879

    Article  CAS  PubMed  Google Scholar 

  126. Fiorino G, Girolomoni G, Lapadula G et al (2014) The use of biosimilars in immune-mediated disease: A joint Italian Society of Rheumatology (SIR), Italian Society of Dermatology (SIDeMaST), and Italian Group of Inflammatory Bowel Disease (IG-IBD) position paper. Autoimmun Rev 13:751–755

    Article  PubMed  Google Scholar 

  127. Sozzani S, Abbracchio MP, Annese V et al (2014) Chronic inflammatory diseases: do immunological patterns drive the choice of biotechnology drugs? A critical review. Autoimmunity 47:287–306

    Article  CAS  PubMed  Google Scholar 

  128. Kivity S, Zafrir Y, Loebstein R, Pauzner R, Mouallem M, Mayan H (2014) Clinical characteristics and risk factors for low dose methotrexate toxicity: a cohort of 28 patients. Autoimmun Rev 13:1109–1113

    Article  CAS  PubMed  Google Scholar 

  129. Favalli EG, Biggioggero M, Meroni PL (2014) Methotrexate for the treatment of rheumatoid arthritis in the biologic era: still an "anchor" drug? Autoimmun Rev 13:1102–1108

    Article  CAS  PubMed  Google Scholar 

  130. Pigott E, DuHadaway JB, Muller AJ, Gilmour S, Prendergast GC, Mandik-Nayak L (2014) 1-Methyl-tryptophan synergizes with methotrexate to alleviate arthritis in a mouse model of arthritis. Autoimmunity 47:409–418

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  131. Versini M, Jeandel PY, Rosenthal E, Shoenfeld Y (2014) Obesity in autoimmune diseases: not a passive bystander. Autoimmun Rev 13:981–1000

    Article  CAS  PubMed  Google Scholar 

  132. Calixto OJ, Anaya JM (2014) Socioeconomic status. The relationship with health and autoimmune diseases. Autoimmun Rev 13:641–654

    Article  PubMed  Google Scholar 

  133. Sattler S, Ling GS, Xu D et al (2014) IL-10-producing regulatory B cells induced by IL-33 (Breg(IL-33)) effectively attenuate mucosal inflammatory responses in the gut. J Autoimmun 50:107–122

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  134. Yang X, Zheng SG (2014) Interleukin-22: a likely target for treatment of autoimmune diseases. Autoimmun Rev 13:615–620

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  135. Chevalier N, Thorburn AN, Macia L et al (2014) Inflammation and lymphopenia trigger autoimmunity by suppression of IL-2-controlled regulatory T cell and increase of IL-21-mediated effector T cell expansion. J Immunol 193:4845–4858

    Article  CAS  PubMed  Google Scholar 

  136. Bessa J, Meyer CA, de Vera Mudry MC et al (2014) Altered subcellular localization of IL-33 leads to non-resolving lethal inflammation. J Autoimmun 55:33–41

    Article  CAS  PubMed  Google Scholar 

  137. Antonelli A, Ferrari SM, Giuggioli D, Ferrannini E, Ferri C, Fallahi P (2014) Chemokine (C-X-C motif) ligand (CXCL)10 in autoimmune diseases. Autoimmun Rev 13:272–280

    Article  CAS  PubMed  Google Scholar 

  138. Maine CJ, Marquardt K, Cheung J, Sherman LA (2014) PTPN22 controls the germinal center by influencing the numbers and activity of T follicular helper cells. J Immunol 192:1415–1424

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  139. Zheng J, Petersen F, Yu X (2014) The role of PTPN22 in autoimmunity: learning from mice. Autoimmun Rev 13:266–271

    Article  CAS  PubMed  Google Scholar 

  140. Raychaudhuri SK, Maverakis E, Raychaudhuri SP (2014) Diagnosis and classification of psoriasis. Autoimmun Rev 13:490–495

    Article  PubMed  Google Scholar 

  141. Ben-Horin S, Kopylov U, Chowers Y (2014) Optimizing anti-TNF treatments in inflammatory bowel disease. Autoimmun Rev 13:24–30

    Article  CAS  PubMed  Google Scholar 

  142. Cassinotti A, Sarzi-Puttini P, Fichera M, Shoenfeld Y, de Franchis R, Ardizzone S (2014) Immunity, autoimmunity and inflammatory bowel disease. Autoimmun Rev 13:1–2

    Article  PubMed  Google Scholar 

  143. Conrad K, Roggenbuck D, Laass MW (2014) Diagnosis and classification of ulcerative colitis. Autoimmun Rev 13:463–466

    Article  CAS  PubMed  Google Scholar 

  144. Fiorino G, Danese S, Pariente B, Allez M (2014) Paradoxical immune-mediated inflammation in inflammatory bowel disease patients receiving anti-TNF-alpha agents. Autoimmun Rev 13:15–19

    Article  CAS  PubMed  Google Scholar 

  145. Geremia A, Biancheri P, Allan P, Corazza GR, Di Sabatino A (2014) Innate and adaptive immunity in inflammatory bowel disease. Autoimmun Rev 13:3–10

    Article  CAS  PubMed  Google Scholar 

  146. Monteleone G, Caruso R, Pallone F (2014) Targets for new immunomodulation strategies in inflammatory bowel disease. Autoimmun Rev 13:11–14

    Article  CAS  PubMed  Google Scholar 

  147. Laass MW, Roggenbuck D, Conrad K (2014) Diagnosis and classification of Crohn's disease. Autoimmun Rev 13:467–471

    Article  PubMed  Google Scholar 

  148. Suzuki E, Mellins ED, Gershwin ME, Nestle FO, Adamopoulos IE (2014) The IL-23/IL-17 axis in psoriatic arthritis. Autoimmun Rev 13:496–502

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  149. Novelli L, Chimenti MS, Chiricozzi A, Perricone R (2014) The new era for the treatment of psoriasis and psoriatic arthritis: perspectives and validated strategies. Autoimmun Rev 13:64–69

    Article  CAS  PubMed  Google Scholar 

  150. Singh RP, Hasan S, Sharma S et al (2014) Th17 cells in inflammation and autoimmunity. Autoimmun Rev 13:1174–1181

    Article  CAS  PubMed  Google Scholar 

  151. Kundu-Raychaudhuri S, Chen YJ, Wulff H, Raychaudhuri SP (2014) Kv1.3 in psoriatic disease: PAP-1, a small molecule inhibitor of Kv1.3 is effective in the SCID mouse psoriasis—xenograft model. J Autoimmun 55:63–72

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  152. Olivieri I, Cantini F, Castiglione F et al (2014) Italian Expert Panel on the management of patients with coexisting spondyloarthritis and inflammatory bowel disease. Autoimmun Rev 13:822–830

    Article  PubMed  Google Scholar 

  153. Granato A, Hayashi EA, Baptista BJ, Bellio M, Nobrega A (2014) IL-4 regulates Bim expression and promotes B cell maturation in synergy with BAFF conferring resistance to cell death at negative selection checkpoints. J Immunol 192:5761–5775

    Article  CAS  PubMed  Google Scholar 

  154. Seok H, Suh DW, Jo B et al (2014) Association between TLR1 polymorphisms and alopecia areata. Autoimmunity 47:372–377

    Article  CAS  PubMed  Google Scholar 

  155. Cordiglieri C, Marolda R, Franzi S et al (2014) Innate immunity in myasthenia gravis thymus: pathogenic effects of Toll-like receptor 4 signaling on autoimmunity. J Autoimmun 52:74–89

    Article  CAS  PubMed  Google Scholar 

  156. Cufi P, Soussan P, Truffault F et al (2014) Thymoma-associated myasthenia gravis: On the search for a pathogen signature. J Autoimmun 52:29–35

    Article  CAS  PubMed  Google Scholar 

  157. Guerrier T, Pochard P, Lahiri A, Youinou P, Pers JO, Jamin C (2014) TLR9 expressed on plasma membrane acts as a negative regulator of human B cell response. J Autoimmun 51:23–29

    Article  CAS  PubMed  Google Scholar 

  158. Manoharan I, Hong Y, Suryawanshi A et al (2014) TLR2-dependent activation of beta-catenin pathway in dendritic cells induces regulatory responses and attenuates autoimmune inflammation. J Immunol 193:4203–4213

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  159. Soni C, Wong EB, Domeier PP et al (2014) B cell-intrinsic TLR7 signaling is essential for the development of spontaneous germinal centers. J Immunol 193:4400–4414

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  160. Wiede F, Ziegler A, Zehn D, Tiganis T (2014) PTPN2 restrains CD8(+) T cell responses after antigen cross-presentation for the maintenance of peripheral tolerance in mice. J Autoimmun 53:105–114

    Article  CAS  PubMed  Google Scholar 

  161. Salmond RJ, Brownlie RJ, Morrison VL, Zamoyska R (2014) The tyrosine phosphatase PTPN22 discriminates weak self peptides from strong agonist TCR signals. Nat Immunol 15:875–883

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  162. Levine AG, Arvey A, Jin W, Rudensky AY (2014) Continuous requirement for the TCR in regulatory T cell function. Nat Immunol 15:1070–1078

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  163. Zang Y, Martinez L, Fernandez I, Pignac-Kobinger J, Greidinger EL (2014) Conservation of pathogenic TCR homology across class II restrictions in anti-ribonucleoprotein autoimmunity: extended efficacy of T cell vaccine therapy. J Immunol 192:4093–4102

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  164. Hogquist KA, Jameson SC (2014) The self-obsession of T cells: how TCR signaling thresholds affect fate 'decisions' and effector function. Nat Immunol 15:815–823

    Article  PubMed Central  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Rheumatology and Clinical Immunology, Humanitas Clinical and Research Center, via A. Manzoni 56, 20089 Rozzano, Milan, Italy

    Carlo Selmi

  2. BIOMETRA Department, University of Milan, Milan, Italy

    Carlo Selmi

Authors
  1. Carlo Selmi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Carlo Selmi.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Selmi, C. Autoimmunity in 2014. Clinic Rev Allerg Immunol 49, 93–99 (2015). https://doi.org/10.1007/s12016-015-8504-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12016-015-8504-9

Keywords

Search

Navigation